๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM ยท Real-Time Price ยท USD
92.49
+0.54 (0.59%)
At close: Nov 18, 2026, 4:00 PM EST
92.60
+0.11 (0.12%)
After-hours: Nov 18, 2026, 4:32 PM EST

Mirum Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
670.78521.31336.89186.3777.0619.14
Revenue Growth
42.18%54.74%80.76%141.85%302.67%-
Gross Profit
548.19421.07255.25139.3464.6917.24
Operating Income
-145.08-22.14-87.61-109.15-131.22-173.41
Net Income
-903.88-23.36-87.94-163.42-135.67-83.99
Earnings Per Share
-15.12-0.47-1.85-4.00-4.02-2.77
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Livmarli
482.36360.01213.3141.875.063.14
Bile Acid Medicines
188.42161.31123.1137.08--
License and Other
--0.487.5216
Revenue (Total)
670.78521.31336.89186.3777.0619.14

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
373.69383.33280.32286.33151.72156.54
Total Debt
743.56319.45317.76308.142.192.61
Net Cash (Debt)
-369.8863.88-37.45-21.82149.53153.93
Net Cash Growth
-----2.86%-32.65%
Net Cash Per Share
-6.181.27-0.79-0.534.405.08

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-271.2655.8310.33-70.94-120.14-132.76
Capital Expenditures
-2.59-0.95-0.99-0.11-0.28-0.02
Free Cash Flow
-273.8554.879.33-71.05-120.41-132.78
Free Cash Flow Growth
-488.01%----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
81.72%80.77%75.77%74.76%83.94%90.06%
Operating Margin
-21.63%-4.25%-26.00%-58.57%-170.28%-906.12%
Pretax Margin
-134.23%-4.11%-25.80%-87.15%-184.36%-438.66%
Profit Margin
-134.75%-4.48%-26.10%-87.68%-176.05%-438.86%
FCF Margin
-40.83%10.53%2.77%-38.12%-156.26%-693.81%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
-74.40212.71---
PS Ratio
9.007.835.897.389.3225.41